Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts

被引:0
作者
Zhichao Zhou
Uthra Rajamani
Hicham Labazi
Stephen L. Tilley
Catherine Ledent
Bunyen Teng
S. Jamal Mustafa
机构
[1] West Virginia University,Department of Physiology and Pharmacology, Center for Cardiovascular and Respiratory Sciences, Clinical and Translational Science Institute
[2] University of North Carolina,Department of Medicine
[3] Universite Libre de Bruxelles,Department of Pathology and Laboratory Medicine
[4] University of California Davis Medical Centre,undefined
来源
Purinergic Signalling | 2015年 / 11卷
关键词
Adenosine; A; receptor knockout; NADPH oxidase; Hydrogen peroxide; Coronary flow;
D O I
暂无
中图分类号
学科分类号
摘要
Adenosine increases coronary flow mainly through the activation of A2A and A2B adenosine receptors (ARs). However, the mechanisms for the regulation of coronary flow are not fully understood. We previously demonstrated that adenosine-induced increase in coronary flow is in part through NADPH oxidase (Nox) activation, which is independent of activation of either A1 or A3ARs. In this study, we hypothesize that adenosine-mediated increase in coronary flow through Nox activation depends on A2A but not A2BARs. Functional studies were conducted using isolated Langendorff-perfused mouse hearts. Hydrogen peroxide (H2O2) production was measured in isolated coronary arteries from WT, A2AAR knockout (KO), and A2BAR KO mice using dichlorofluorescein immunofluorescence. Adenosine-induced concentration-dependent increase in coronary flow was attenuated by the specific Nox2 inhibitor gp91 ds-tat or reactive oxygen species (ROS) scavenger EUK134 in both WT and A2B but not A2AAR KO isolated hearts. Similarly, the A2AAR selective agonist CGS-21680-induced increase in coronary flow was significantly blunted by Nox2 inhibition in both WT and A2BAR KO, while the A2BAR selective agonist BAY 60-6583-induced increase in coronary flow was not affected by Nox2 inhibition in WT. In intact isolated coronary arteries, adenosine-induced (10 μM) increase in H2O2 formation in both WT and A2BAR KO mice was attenuated by Nox2 inhibition, whereas adenosine failed to increase H2O2 production in A2AAR KO mice. In conclusion, adenosine-induced increase in coronary flow is partially mediated by Nox2-derived H2O2, which critically depends upon the presence of A2AAR.
引用
收藏
页码:263 / 273
页数:10
相关论文
共 26 条
[21]   Role of A2A-adenosine receptor activation for ATP-mediated coronary vasodilation in guinea-pig isolated heart [J].
Erga, KS ;
Seubert, CN ;
Liang, HX ;
Wu, L ;
Shryock, JC ;
Belardinelli, L .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (05) :1065-1075
[22]   Activation of NADPH Oxidase by Adenosine in Isolated Heart and Coronary Artery Smooth Muscle Cells Involves Phosphorylation of ERK 1/2 And P47-phox: Role of At and A3 Adenosine Receptors [J].
El-Awady, Mohammed ;
Fil, Daniel ;
Teng, Bunyen ;
Tilley, Stephen S. ;
Mustafa, S. Jamal .
CIRCULATION, 2012, 126 (21)
[23]   Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission [J].
Nascimento, Filipe ;
Sebastiao, Ana M. ;
Ribeiro, Joaquim A. .
PURINERGIC SIGNALLING, 2015, 11 (04) :471-480
[24]   Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission [J].
Filipe Nascimento ;
Ana M. Sebastião ;
Joaquim A. Ribeiro .
Purinergic Signalling, 2015, 11 :471-480
[25]   Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes [J].
Belambri, Sahra Amel ;
Hurtado-Nedelec, Margarita ;
Senator, Abderrahmane ;
Makni-Maalej, Karama ;
Fay, Michele ;
Gougerot-Pocidalo, Marie-Anne ;
Marie, Jean-Claude ;
Dang, Pham My-Chan ;
El-Benna, Jamel .
AMERICAN JOURNAL OF BLOOD RESEARCH, 2012, 2 (03) :187-193
[26]   Myocardial blood flow and myocardial uptake of 201Tl and 99mTc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A2A receptor agonist [J].
He, ZX ;
Cwajg, E ;
Hwang, W ;
Hartley, CJ ;
Funk, E ;
Michael, LH ;
Verani, MS .
CIRCULATION, 2000, 102 (04) :438-444